Olshan Advises Largest Stockholder of Pharmacyclics, Inc.

Firm News

Olshan advised the largest Stockholder of Pharmacyclics, Inc. which announced successful negotiations resulting in four out of six board members of the board being replaced with the Stockholder's designees, thereby avoiding a proxy contest. Steve Wolosky represented the Stockholder.

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.